Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms

Deborah A Howatt1, Maya Dajee2, Xiaojie Xie1,3

  • 1Saha Cardiovascular Research Center, University of Kentucky.

Abstract

Insights

Matrix metalloproteinase-9 (MMP-9) deficiency augmented angiotensin II-induced abdominal aortic aneurysms (AAA). Relaxin did not influence AAA, but affected MMP-9 expression in macrophages.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Biochemistry

Background:

  • Abdominal aortic aneurysms (AAA) are a significant cause of mortality.
  • The roles of relaxin and matrix metalloproteinase-9 (MMP-9) in AAA pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the influence of relaxin and MMP-9 on angiotensin II (AngII)-induced AAA.
  • To elucidate the specific mechanisms by which these factors affect AAA development.

Main Methods:

  • AngII infusion in male C57BL/6 and apolipoprotein E knockout mice, with or without relaxin administration.
  • Analysis of MMP-9 mRNA expression in macrophages.
  • Assessment of AAA incidence and aortic rupture in MMP-9 deficient mice.

Main Results:

  • Relaxin did not affect AngII-induced AAA formation in either mouse strain.
  • AngII infusion decreased MMP-9 mRNA, while relaxin increased it in macrophages.
  • MMP-9 deficiency led to AAA formation without AngII and worsened AngII-induced aortic rupture and AAA incidence.

Conclusions:

  • MMP-9 deficiency significantly augmented AngII-induced AAA.
  • These findings highlight a critical role for MMP-9 in AAA progression and suggest potential therapeutic targets.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...